❌

Normal view

Received before yesterday

F.T.C. Settles With Express Scripts Over High Insulin Prices

4 February 2026 at 16:40
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices.

Β© Sarah Holm/The Virginian-Pilot, via Associated Press

High insulin prices generated public outcry for years, though changes in the past few years have reduced patients’ costs to no more than $35 a month in most cases.

Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices

4 February 2026 at 05:00
The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.

Β© Carolyn Kaster/Associated Press

Executives at the largest pharmacy benefit managers testified before a congressional committee in 2023.

Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers

22 January 2026 at 18:28
At two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of medical care for consumers.

Β© Kylie Cooper/Reuters

Stephen Hemsley, chief executive of UnitedHealth Group, left, defended insurers’ practices, along with other companies’ executives, during congressional hearings on Thursday.

Kaiser Permanente Agrees to Pay $556 Million to Settle Medicare Overbilling Claims

The Justice Department and whistle-blowers accused the major health insurer of overbilling the government for about $1 billion under the private plans.

Β© Rachel Woolf for The New York Times

Dr. James Taylor, a physician and coding expert who worked for Kaiser Permanente, was one of the whistle-blowers who flagged the overbilling. β€œThe cash monster was insatiable,” he said.
❌